Skip to main content

Table 1 Differentiated dysregulation of miRNAs in ESCC

From: Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma

miRNA

Fold change

 

hsa-miR-99a-5p

5.64

down

hsa-miR-140-3p

5.21

down

hsa-miR-125b-5p

5.08

down

hsa-miR-30b-5p

4.99

down

hsa-miR-126-3p

4.63

down

hsa-miR-30a-5p

4.48

down

hsa-miR-26a-5p

4.24

down

hsa-miR-29a-3p

4.01

down

hsa-miR-150-5p

3.43

down

hsa-miR-142-5p

3.22

down

hsa-miR-27b-3p

3.13

down

hsa-let-7a-5p

2.38

down

hsa-miR-22-3p

2.21

down

hsa-miR-6069

2.18

down

hsa-let-7f-5p

2.15

down

hsa-miR-193b-3p

2.14

down

hsa-miR-31-5p*

2.63

up

hsa-miR-1273e

2.48

up

hsa-miR-483-5p

2.45

up

hsa-miR-4793-5p

2.44

up

hsa-miR-6510-5p

2.37

up

hsa-miR-642b-3p

2.15

up

hsa-miR-765

2.11

up

hsa-miR-371a-5p

2.07

up

hsa-miR-4485

2.04

up

hsa-miR-4800-5p

2.02

up

hsa-miR-3141

1.98

up

hsa-miR-575

1.96

up

hsa-miR-21-5p

1.94

up

hsa-miR-93-5p

1.84

up

hsa-miR-4499

1.77

up

hsa-miR-188-5p

1.62

up

hsa-miR-106b-5p

1.54

up

  1. *MiRNAs with more than 1.5-fold expression change in ESCC tissues relative to expression in matched normal tissues
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us